The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....
Read moreMon–Thu 8–18, Fri 8–16
With an ultrasound examination it is possible to find out more about the nature of the change in the breast. Ultrasound is harmless and effortless for the patient.
If you find a lump in your breast, we recommend mammography and an ultrasound as the primary tests. If necessary, we also take a needle aspirate sample, and if the results show anything indicative of cancer, we start investigating the tumor staging and size with tests such as MRI scan.
Ultrasound imaging is based on loopback technology that applies sound waves. Ultrasound is used to supplement mammography and MRI scan.
A real-time ultrasound also helps us guide the needle when taking a needle aspirate sample. A needle aspirate sample, in other words a biopsy, is usually taken if previous test results have contained anything suspicious. Based on the tissue sample from the biopsy, the pathologist determines the type of breast cancer and the differentiation rate as well as other factors important for treatment, if necessary. The pathologist’s results take a few weekdays to arrive.
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....
Read more
Breast cancer is a serious disease that requires individual care and expertise. As part of cancer treatment, the patient may...
Docrates treats metastatic colorectal cancer in a personalised way, and its treatment recommendations are based on the latest research and...
Cancer is a rapidly evolving medical specialty. Docrates publishes the latest news about cancer treatment, diagnostics and research a number...
Contact us!
Mon-Thu 8:00-18:00, Fri 8:00-16:00